Join us to learn about the Advantages & Disadvantages of
Adaptive Sample Size Re-Estimation and how these can impact your trial.
Adaptive clinical trials seek to give control to trialist to improve the trial based on all available information. Given the high failure rates and the increased costs of clinical trials, researchers need such innovative design strategies to best optimize financial resources and reduce the risk to patients.
Speaker: Ronan Fitzpatrick, Head of Statistics, Statsols
About Our Host
Ronan Fitzpatrick is Head of Statistics at Statsols and the Lead Researcher for nQuery Sample Size Software. He has been a guest lecturer for many institutions including the FDA.